Page URL: https://www.bionews.org.uk/nicolettacharolidi

Dr Nicoletta Charolidi

Dr Nicoletta Charolidi is a Volunteer Writer at BioNews, and a Volunteer at the charity that publishes it, the Progress Educational Trust (PET). She is the Manager of the Imperial Advanced Therapy Medicinal Products (ATMP) Centre and a Knowledge Exchange Practitioner for London Advanced Therapies, an alliance between UCL, Imperial and King's College. Her role is to advance gene and cell therapy in London by promoting cross-academia and industry-academia collaborations and partnerships in this field.

Previously, she trained as a molecular vascular biologist with a PhD from Imperial College London's National Heart and Lung Institute and followed by postdoctoral work at University College London's Institute of Child Health and St George's, University of London's Institute of Molecular and Clinical Sciences. Her interests include promoting popularisation of medical sciences and public understanding of translational research.


BioNews Comment articles written by Dr Nicoletta Charolidi:
Page 1 of 1
A patchwork of policies: assisted conception and embryo research in Europe
14 January 2019 - by Dr Nicoletta Charolidi
This session of the Progress Educational Trust's 2018 Annual Conference 'Make Do or Amend: Should We Update UK Fertility and Embryo Law?' gave an overview of the regulatory framework of assisted conception and embryo research in Europe... [Read More]
The Real Cost of IVF
16 April 2018 - by Dr Nicoletta Charolidi
'The Real Cost of IVF' event organised by Progress Educational Trust (PET), despite its an ambiguous title, had a very specific purpose: to acknowledge, discuss, and to raise awareness of the emotional and psychological price paid by people who undergo fertility treatment... [Read More]
Testing, Testing 1, 2, 3: PGS and PGD
26 September 2016 - by Dr Nicoletta Charolidi
There was a captivating debate around the emerging genetic choices, legal framework and ethical issues from the use of PGS (pre-implantation genetic screening) and PGD (pre-implantation genetic diagnosis) at this event produced by the Progress Educational Trust (PET)... [Read More]
What is the germline?
21 December 2015 - by Dr Nicoletta Charolidi
We report from the first session of the annual conference of the Progress Educational Trust, titled 'From Three-Person IVF to Genome Editing: the Science and the Ethics of Engineering the Embryo', in which Professor Azim Surani discussed the germline... [Read More]
A TripAdvisor for fertility clinics - would you recommend it?
18 May 2015 - by Dr Nicoletta Charolidi
At this Progress Educational Trust event there was a lively debate about whether and how the HFEA should collect feedback from patients about fertility clinics across the UK and publish it on its website... [Read More]
Genetic conditions: How should your DNA be used in the 100,000 Genomes Project?
10 November 2014 - by Dr Nicoletta Charolidi
At this Progress Educational Trust (PET) and Genomics England event on the use of data in the 100,000 Genomes Project, a panel of experts had the opportunity to reflect on the goals of the project and respond to audience questions... [Read More]

BioNews Review articles written by Dr Nicoletta Charolidi:
Page 1 of 1
Book Review: The Essential Fertility Guide
25 January 2016 - by Dr Nicoletta Charolidi
For couples who have difficulty in conceiving naturally, this is an excellent guide by Professor Robert Winston on the main causes of infertility... [Read More]

BioNews News articles written by Dr Nicoletta Charolidi:
Page 1 of 3
Next-generation genomic research platform launched in the UK for COVID-19
6 July 2020 - by Dr Nicoletta Charolidi
Genomics England has launched a new, secure, data-processing platform for global COVID-19 genomic research... [Read More]
World's first liver stem cell transplant to a newborn baby
26 May 2020 - by Dr Nicoletta Charolidi
A newborn baby with a severe liver disorder has been successfully treated with liver cells derived from embryonic stem cells... [Read More]
Neighbour cells implicated in colorectal cancer
6 April 2020 - by Dr Nicoletta Charolidi
A new study characterising the microenvironment of colorectal cancers has revealed a distinct population of cells, residing next to tumour-initiating stem cells, which themselves promote the start of tumour growth in the colon... [Read More]
RNA sequencing used to investigate sperm microbiome
3 February 2020 - by Dr Nicoletta Charolidi
RNA sequencing has been used for the characterisation of pathogens in human sperm, giving the potential to be used as a new diagnostic tool for infertility investigations... [Read More]
Healthy bone marrow may be important in fertility
23 September 2019 - by Dr Nicoletta Charolidi
A study in mice suggests that bone marrow-derived stem cells may play a role in establishing pregnancy... [Read More]
NHS approves earlier use of 'game-changing' ovarian cancer drug
29 July 2019 - by Dr Nicoletta Charolidi
Women in England with advanced ovarian cancer will now have access to a drug that could help halt the progression of their disease much earlier in their course of treatment... [Read More]
Father's nicotine use risks cognitive problems down the generations
22 October 2018 - by Dr Nicoletta Charolidi
A father's smoking habit can cause cognitive deficits in the second and third generations, a study in mice has shown... [Read More]
First fetus to be enrolled in stem-cell transplant trial
4 June 2018 - by Dr Nicoletta Charolidi
The first in utero stem cell transplant trial has welcomed its first baby - born after being treated in the womb with her mother's stem cells... [Read More]
Genome studies shed light on childhood cancers
5 March 2018 - by Dr Nicoletta Charolidi
Two separate genomic studies of childhood cancers reveal differences compared with adult cancers, potentially opening new therapeutic avenues... [Read More]
Single molecule found for breast cancer spread
12 February 2018 - by Dr Nicoletta Charolidi
Blocking a single molecule, the amino acid asparagine, can prevent breast cancer spread in mice, according to a new study... [Read More]